Genetic Technologies validates breast cancer risk test

Genetic Technologies (GTG), a Melbourne company whose technology predicts the likelihood of serious disease, has received validation of the benefits of its gene Type Breast Cancer Risk Assessment Test. The company, a leader in geonomics-based tests, announced the completion of a customisable Budget Impact Model (Bim) which ‘demonstrates significant health and economic benefits directly attributed…